Bank of Montreal Can purchased a new stake in Amsurg Corp. (NASDAQ:AMSG) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 466,176 shares of the company’s stock, valued at approximately $36,148,000.
Other large investors have also modified their holdings of the company. Invictus RG increased its position in Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares during the last quarter. Checchi Capital Advisers LLC purchased a new position in Amsurg Corp. during the second quarter valued at approximately $157,000. Oakbrook Investments LLC purchased a new position in Amsurg Corp. during the second quarter valued at approximately $209,000. Mount Lucas Management LP increased its position in Amsurg Corp. by 10.3% in the first quarter. Mount Lucas Management LP now owns 3,483 shares of the company’s stock valued at $260,000 after buying an additional 326 shares during the last quarter. Finally, Bayesian Capital Management LP purchased a new position in Amsurg Corp. during the first quarter valued at approximately $275,000. Hedge funds and other institutional investors own 98.42% of the company’s stock.
Amsurg Corp. (NASDAQ:AMSG) traded down 1.16% during mid-day trading on Friday, hitting $64.78. The stock had a trading volume of 1,051,483 shares. The stock has a market cap of $3.48 billion, a P/E ratio of 19.22 and a beta of 0.65. The firm has a 50-day moving average of $65.74 and a 200-day moving average of $73.68. Amsurg Corp. has a 52-week low of $58.37 and a 52-week high of $87.29.
Amsurg Corp. (NASDAQ:AMSG) last announced its earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.02. The company had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The firm’s quarterly revenue was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.97 earnings per share. On average, analysts forecast that Amsurg Corp. will post $4.33 EPS for the current fiscal year.
Several research analysts have commented on the company. Barclays PLC assumed coverage on Amsurg Corp. in a report on Wednesday, June 1st. They set an “equal weight” rating and a $85.00 price objective on the stock. Zacks Investment Research raised Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 target price on the stock in a research report on Monday, July 11th. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Amsurg Corp. in a research report on Friday, June 17th. Robert W. Baird reaffirmed a “buy” rating on shares of Amsurg Corp. in a research report on Thursday, June 16th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 target price on shares of Amsurg Corp. in a research report on Thursday, July 14th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $93.90.
In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $64.36, for a total value of $482,700.00. Following the sale, the insider now owns 105,007 shares of the company’s stock, valued at $6,758,250.52. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.30% of the stock is owned by company insiders.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.